Latest venBio Partners LLC Stock Portfolio
venBio Partners LLC Performance:
2025 Q3: 44.35%YTD: 0.65%2024: -53.75%
Performance for 2025 Q3 is 44.35%, and YTD is 0.65%, and 2024 is -53.75%.
About venBio Partners LLC and 13F Hedge Fund Stock Holdings
In it's latest 13F Holdings report, venBio Partners LLC reported an equity portfolio of $176.4 Millions as of 30 Sep, 2025.
The top stock holdings of venBio Partners LLC are PHVS, , ALXO. The fund has invested 65.6% of it's portfolio in PHARVARIS N V and 10.4% of portfolio in ALUMIS INC.
The fund showed a lot of confidence in some stocks as they added substantially to PHARVARIS N V (PHVS).
The top stock holdings of venBio Partners LLC are PHVS, , ALXO. The fund has invested 65.6% of it's portfolio in PHARVARIS N V and 10.4% of portfolio in ALUMIS INC.
The fund showed a lot of confidence in some stocks as they added substantially to PHARVARIS N V (PHVS).
venBio Partners LLC Annual Return Estimates Vs S&P 500
Our best estimate is that venBio Partners LLC made a return of 44.35% in the last quarter. In trailing 12 months, it's portfolio return was -11.91%.
New Buys
Additions
| Ticker | % Inc. |
|---|---|
| pharvaris n v | 8.16 |
Additions to existing portfolio by venBio Partners LLC
Reductions
Sold off
Sector Distribution
venBio Partners LLC has about 77.9% of it's holdings in Others sector.
| Sector | % |
|---|---|
| Others | 77.9 |
| Healthcare | 22.1 |
Market Cap. Distribution
venBio Partners LLC has about 0% of it's portfolio invested in the large-cap and mega-cap stocks.
| Category | % |
|---|---|
| UNALLOCATED | 77.9 |
| SMALL-CAP | 12 |
| MICRO-CAP | 10.1 |
Stocks belong to which Index?
About 22.1% of the stocks held by venBio Partners LLC either belong to S&P 500 or RUSSELL 2000 index.
| Index | % |
|---|---|
| Others | 77.9 |
| RUSSELL 2000 | 22.1 |
venBio Partners LLC Holdings Map
This heatmap illustrates the top 50 positions within the fund's portfolio.
Current Stock Holdings of venBio Partners LLC
venBio Partners LLC has 6 stocks in it's portfolio. HRMY proved to be the most loss making stock for the portfolio. PHVS was the most profitable stock for venBio Partners LLC last quarter.
Last Reported on: 14 Nov, 2025| Ticker | Namesorted ascending | % Portfolio | Shares Held | $ Value | Type | % Change | Options | |
|---|---|---|---|---|---|---|---|---|
| ALXO | alx oncology hldgs inc | 10.06 | 9,699,920 | 17,750,900 | unchanged | 0.00 | ||
| HRMY | harmony biosciences hldgs in | 7.64 | 489,194 | 13,482,200 | unchanged | 0.00 | ||
| LYEL | lyell immunopharma inc | 4.36 | 473,479 | 7,689,300 | unchanged | 0.00 | ||
| PHVS | pharvaris n v | 65.62 | 4,639,300 | 115,751,000 | added | 8.16 | ||
| alumis inc | 10.45 | 4,619,800 | 18,433,000 | unchanged | 0.00 | |||
| artiva biotherapeutics inc | 1.87 | 1,148,980 | 3,297,560 | unchanged | 0.00 | |||